The frequency of epidermal growth factor receptor mutation of nonsmall cell lung cancer according to the underlying pulmonary diseases

Pulmonary Medicine

Volumn , Issue , 2011, Pages

  Usui, Kazuhiro ^a   Ushijima, Tomonori ^a   Tanaka, Yoshiaki ^a   Tanai, Chiharu ^a   Noda, Hiromichi ^a   Abe, Norifumi ^a   Horiuchi, Hajime ^a   Ishihara, Teruo ^a  

^a Kanto Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER SURVIVAL; DISEASE ASSOCIATION; FATALITY; FEMALE; GENE MUTATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG CARCINOGENESIS; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SMOKING;

EID: 84876243498     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2011/290132     Document Type: Review

References (18)

1. Fukuoka M., Yano S., Giaccone G., Tamura T., Nakagawa K., Douillard J. -Y., Nishiwaki Y., Vansteenkiste J., Kudoh S., Rischin D., Eek R., Horai T., Noda K., Takata I., Smit E., Averbuch S., Macleod A., Feyereislova A., Dong R. -P., Baselga J., Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer Journal of Clinical Oncology 2003 21 12 2237 2246. Erratum in: Journal of Clinical Oncology, vol. 22, no. 23, pp. 4811, 2004 (Pubitemid 46621858)
2. Lynch T. J., Bell D. W., Sordella R., Gurubhagavatula S., Okimoto R. A., Brannigan B. W., Harris P. L., Haserlat S. M., Supko J. G., Haluska F. G., Louis D. N., Christiani D. C., Settleman J., Haber D. A., Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib New England Journal of Medicine 2004 350 21 2129 2139 (Pubitemid 38637993)
3. Paez J. G., Jnne P. A., Lee J. C., Tracy S., Greulich H., Gabriel S., Herman P., Kaye F. J., Lindeman N., Boggon T. J., Naoki K., Sasaki H., Fujii Y., Eck M. J., Sellers W. R., Johnson B. E., Meyerson M., EGFR mutations in lung, cancer: correlation with clinical response to gefitinib therapy Science 2004 304 5676 1497 1500 (Pubitemid 38720929)
4. Mitsudomi T., Kosaka T., Endoh H., Horio Y., Hida T., Mori S., Hatooka S., Shinoda M., Takahashi T., Yatabe Y., Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence Journal of Clinical Oncology 2005 23 11 2513 2520 (Pubitemid 47050841)
5. Toyooka S., Takano T., Kosaka T., Hotta K., Matsuo K., Ichihara S., Fujiwara Y., Soh J., Otani H., Kiura K., Aoe K., Yatabe Y., Ohe Y., Mitsudomi T., Date H., Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma Cancer Science 2008 99 2 303 308 (Pubitemid 351228484)
6. Mitsudomi T., Morita S., Yatabe Y., Negoro S., Okamoto I., Tsurutani J., Seto T., Satouchi M., Tada H., Hirashima T., Asami K., Katakami N., Takada M., Yoshioka H., Shibata K., Kudoh S., Shimizu E., Saito H., Toyooka S., Nakagawa K., Fukuoka M., Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial The Lancet Oncology 2010 11 2 121 128
7. Maemondo M., Inoue A., Kobayashi K., Sugawara S., Oizumi S., Isobe H., Gemma A., Harada M., Yoshizawa H., Kinoshita I., Fujita Y., Okinaga S., Hirano H., Yoshimori K., Harada T., Ogura T., Ando M., Miyazawa H., Tanaka T., Saijo Y., Hagiwara K., Morita S., Nukiwa T., Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR New England Journal of Medicine 2010 362 25 2380 2388
8. Cohen M. H., Williams G. A., Sridhara R., Chen G., Pazdur R., FDA drug approval summary: gefitinib (ZD1839) (Iressa ) tablets Oncologist 2003 8 4 303 306 (Pubitemid 36929716)
9. Ando M., Okamoto I., Yamamoto N., Takeda K., Tamura K., Seto T., Ariyoshi Y., Fukuoka M., Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib Journal of Clinical Oncology 2006 24 16 2549 2556 (Pubitemid 46630633)
10. Kudoh S., Kato H., Nishiwaki Y., Fukuoka M., Nakata K., Ichinose Y., Tsuboi M., Yokota S., Nakagawa K., Suga M., Jiang H., Itoh Y., Armour A., Watkins C., Higenbottam T., Nyberg F., Johkoh T., Takahashi M., Ohno Y., Kusumoto M., Arakawa H., Sakai F., Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study American Journal of Respiratory and Critical Care Medicine 2008 177 12 1348 1357 (Pubitemid 351860912)
11. Cottin V., Nunes H., Brillet P. Y., Delaval P., Devouassaoux G., Tillie-Leblond I., Israel-Biet D., Court-Fortune I., Valeyre D., Cordier J. F., Carré P., Chabot F., Chatté G., Cotmeur D., Crestani B., Dalphin J. C., Dietemann A., Gentil B., Humbert M., Lacronique J., Mairesse M., Marchand E., Reynaud-Gaubert M., Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity European Respiratory Journal 2005 26 4 586 593 (Pubitemid 41448654)
12. Usui K., Tanai C., Tanaka Y., Noda H., Ishihara T., The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer Respirology 2011 16 2 326 331
13. Sutani A., Nagai Y., Udagawa K., Uchida Y., Koyama N., Murayama Y., Tanaka T., Miyazawa H., Nagata M., Kanazawa M., Hagiwara K., Kobayashi K., Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp British Journal of Cancer 2006 95 11 1483 1489 (Pubitemid 44863350)
14. Hung R. J., McKay J. D., Gaborieau V., Boffetta P., Hashibe M., Zaridze D., Mukeria A., Szeszenia-Dabrowska N., Lissowska J., Rudnai P., Fabianova E., Mates D., Bencko V., Foretova L., Janout V., Chen C., Goodman G., Field J. K., Liloglou T., Xinarianos G., Cassidy A., McLaughlin J., Liu G., Narod S., Krokan H. E., Skorpen F., Elvestad M. B., Hveem K., Vatten L., Linseisen J., Clavel-Chapelon F., Vineis P., Bueno-De-Mesquita H. B., Lund E., Martinez C., Bingham S., Rasmuson T., Hainaut P., Riboli E., Ahrens W., Benhamou S., Lagiou P., Trichopoulos D., Holctov I., Merletti F., Kjaerheim K., Agudo A., MacFarlane G., Talamini R., Simonato L., Lowry R., Conway D. I., Znaor A., Healy C., Zelenika D., Boland A., Delepine M., Foglio M., Lechner D., Matsuda F., Blanche H., Gut I., Heath S., Lathrop M., Brennan P., A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 Nature 2008 452 7187 633 637 (Pubitemid 351483367)
15. Thorgeirsson T. E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K. P., Manolescu A., Thorleifsson G., Stefansson H., Ingason A., Stacey S. N., Bergthorsson J. T., Thorlacius S., Gudmundsson J., Jonsson T., Jakobsdottir M., Saemundsdottir J., Olafsdottir O., Gudmundsson L. J., Bjornsdottir G., Kristjansson K., Skuladottir H., Isaksson H. J., Gudbjartsson T., Jones G. T., Mueller T., Gottster A., Flex A., Aben K. K. H., De Vegt F., Mulders P. F. A., Isla D., Vidal M. J., Asin L., Saez B., Murillo L., Blondal T., Kolbeinsson H., Stefansson J. G., Hansdottir I., Runarsdottir V., Pola R., Lindblad B., Van Rij A. M., Dieplinger B., Haltmayer M., Mayordomo J. I., Kiemeney L. A., Matthiasson S. E., Oskarsson H., Tyrfingsson T., Gudbjartsson D. F., Gulcher J. R., Jonsson S., Thorsteinsdottir U., Kong A., Stefansson K., A variant associated with nicotine dependence, lung cancer and peripheral arterial disease Nature 2008 452 7187 638 642 (Pubitemid 351483366)
16. Lambrechts D., Buysschaert I., Zanen P., Coolen J., Lays N., Cuppens H., Groen H. J. M., Dewever W., Van Klaveren R. J., Verschakelen J., Wijmenga C., Postma D. S., Decramer M., Janssens W., The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema American Journal of Respiratory and Critical Care Medicine 2010 181 5 486 493
17. Young R. P., Hopkins R. J., Christmas T., Black P. N., Metcalf P., Gamble G. D., COPD prevalence is increased in lung cancer, independent of age, sex and smoking history European Respiratory Journal 2008 34 2 380 386
18. Hubbard R., Venn A., Lewis S., Britton J., Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study American Journal of Respiratory and Critical Care Medicine 2000 161 1 5 8 (Pubitemid 30055895)